Mishra et al., 2018 - Google Patents
CPTP: A sphingolipid transfer protein that regulates autophagy and inflammasome activationMishra et al., 2018
View HTML- Document ID
- 4302190809158555281
- Author
- Mishra S
- Gao Y
- Deng Y
- Chalfant C
- Hinchcliffe E
- Brown R
- Publication year
- Publication venue
- Autophagy
External Links
Snippet
The macroautophagy/autophagy and inflammasome pathways are linked through their roles in innate immunity and chronic inflammatory disease. Ceramide-1-phosphate (C1P) is a bioactive sphingolipid that regulates pro-inflammatory eicosanoid production. Whether C1P …
- 102100009110 CPTP 0 title abstract description 215
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mishra et al. | CPTP: A sphingolipid transfer protein that regulates autophagy and inflammasome activation | |
| Kim et al. | TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lysosomal calcium | |
| Wang et al. | Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia | |
| Zhang et al. | Polyamines control eIF5A hypusination, TFEB translation, and autophagy to reverse B cell senescence | |
| Chao et al. | Metabolic control of astrocyte pathogenic activity via cPLA2-MAVS | |
| Li et al. | p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities | |
| Chen-Plotkin et al. | TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways | |
| Durieux et al. | A centronuclear myopathy–dynamin 2 mutation impairs autophagy in mice | |
| Chen et al. | m6A modification of circSPECC1 suppresses RPE oxidative damage and maintains retinal homeostasis | |
| Zhang et al. | Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization | |
| Li et al. | Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance | |
| Koch et al. | Proper synaptic vesicle formation and neuronal network activity critically rely on syndapin I | |
| Sobota et al. | Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal-and secretory-pathway proteins | |
| Zhang et al. | Degradation of NLRP3 by p62‐dependent‐autophagy improves cognitive function in Alzheimer's disease by maintaining the phagocytic function of microglia | |
| Hwang et al. | Transgelin 2 guards T cell lipid metabolism and antitumour function | |
| Naydenov et al. | Adducins regulate remodeling of apical junctions in human epithelial cells | |
| Jiang et al. | LZTFL1 upregulated by all-trans retinoic acid during CD4+ T cell activation enhances IL-5 production | |
| Luizet et al. | The Brucella effector BspL targets the ER-associated degradation (ERAD) pathway and delays bacterial egress from infected cells | |
| Wang et al. | KCTD7 mutations impair the trafficking of lysosomal enzymes through CLN5 accumulation to cause neuronal ceroid lipofuscinoses | |
| Naydenov et al. | A membrane fusion protein αSNAP is a novel regulator of epithelial apical junctions | |
| Bambouskova et al. | New regulatory roles of galectin-3 in high-affinity IgE receptor signaling | |
| Dowdell et al. | The HIF target ATG9A is essential for epithelial barrier function and tight junction biogenesis | |
| Balnis et al. | Deaccelerated myogenesis and autophagy in genetically induced pulmonary emphysema | |
| Guerrero-Ros et al. | The negative effect of lipid challenge on autophagy inhibits T cell responses | |
| Falguières et al. | Regulation of the MVB pathway by SCAMP3 |